Dyspnea
📧 Sign up to get email alerts when something new happens for Dyspnea.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-11-22Clinical Trial Update: ExoFlo™ Infusion for Post-Acute COVID-19 and Chronic Post-COVID-19 Syndrome [Phase 1, Phase 2]
A Phase 1/2 trial of ExoFlo Infusion for post-acute COVID-19 and chronic post-COVID-19 syndrome has been withdrawn by the sponsor.
-
CLINICAL_TRIALS withdrawal · 2023-02-03Clinical Trial Update: Inhaled ZYESAMI (Aviptadil Acetate) for Treatment of Severe COVID-19 [Phase 3]
Phase 3 clinical trial of inhaled aviptadil acetate (ZYESAMI) for severe COVID-19 has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-01-12Clinical Trial Update: Opioids for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease [Phase 3]
A Phase 3 trial evaluating opioids for refractory breathlessness in chronic obstructive pulmonary disease has been withdrawn.